Opiran en es it fr

Opiran Brand names, Opiran Analogs

Opiran Brand Names Mixture

  • No information avaliable

Opiran Chemical_Formula


Opiran RX_link


Opiran fda sheet

Opiran msds (material safety sheet)

Opiran MSDS

Opiran Synthesis Reference

No information avaliable

Opiran Molecular Weight

461.546 g/mol

Opiran Melting Point

214-218 oC

Opiran H2O Solubility

10 mg/L

Opiran State


Opiran LogP


Opiran Dosage Forms


Opiran Indication

Used for the suppression of motor and phonic tics in patients with Tourette's Disorder who have failed to respond satisfactorily to standard treatment.

Opiran Pharmacology

Pimozide is an orally active antipsychotic drug product which shares with other antipsychotics the ability to blockade dopaminergic receptors on neurons in the central nervous system. However, receptor blockade is often accompanied by a series of secondary alterations in central dopamine metabolism and function which may contribute to both pimozide's therapeutic and untoward effects. In addition, pimozide, in common with other antipsychotic drugs, has various effects on other central nervous system receptor systems which are not fully characterized. Pimozide also has less potential for inducing sedation and hypotension as it has more specific dopamine receptor blocking activity than other neuroleptic agents (and is therefore a suitable alternative to haloperidol).

Opiran Absorption

Greater than 50% absorption after oral administration. Serum peak appears 6-8 hours post ingestion.

Opiran side effects and Toxicity

LD50 = 1100 mg/kg (rat, oral), 228 mg/kg (mouse, oral)

Opiran Patient Information

No information avaliable

Opiran Organisms Affected

Humans and other mammals